Spring 2021                   Back to the articles list | Back to browse issues page

XML Print


1- Community Medicine, Metabolic Diseases Research Center, Research Institute For Prevention Of Non-Communicable Diseases, Qazvin University Of Medical Sciences, Qazvin, Iran.
2- Assistant professor of neurology,Qazvin University Of Medical Sciences, Qazvin, Iran
3- Medical Student, Student Research Committee, Qazvin University of Medical Sciences, Qaz
4- Department of community medicine, School of Medicine,Bushehr University of Medical Sciences, Bushehr, Iran , motamedn@bpums.ac.ir
Abstract:   (158 Views)
Background: Cerebrovascular diseases are the second common cause of mortality all over the world. Onset of reperfusion during first 3-4.5 hours is a predictive factor of treatment.
Objective: In the present study, we investigated barriers to receiving tissue plasminogen activator in patients with ischemic stroke referred to the Bushehr Persian Gulf Martyrs Hospital in 2016.
Methods: In this cross sectional study, 191 patients suffering from first ever stroke which visited emergency department of the  Persian Gulf Martyrs Hospital of Bushehr in 2016, were investigated. One checklist was completed which included demographic data, history of diseases, knowledge of stroke symptoms and intervals regarding onset of symptoms to informing emergency, informing of emergency to arrival at emergency department of hospital and finally making diagnosis for the patients. Data were analyzed in SPSS software version 18.
Findings: Mean age of the patients was 65.92±12.48 years. The majority of patients under investigation (55.5%) were female, 63.4% were married, 56% were illiterate and 72.3% resided in other districts of Bushehr province. Mean duration between onset of symptoms and arrival at emergency department, onset of symptoms and call the emergency service, time of arrival at emergency department to perform brain computer tomography (CT) scan and also to be counseled by a neurologist were 699.66, 195.51, 45.11 and 423.62 minutes, respectively. Finally 14.6 percent of patients were qualified to be treated with tPA.
Conclusion: The main barrier to timely therapy is delay in golden time. Therefore, public education to promote public awareness could be of great benefit in reducing the referral delay time.
     
Type of Study: Research | Subject: Neurology

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb